Pharmaceuticals Short Bowel Syndrome Drugs Market F...

Short Bowel Syndrome Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Glucagon-like Peptide, Anti-Diarrheals, Proton Pump Inhibitors, Histamine Blockers, Growth Hormone, Others); Distribution Channel (Hospital and Retail Pharmacies, Online Distribution), and Geography

Report Code: TIPRE00021601 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Get Free Sample PDF
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Short bowel syndrome (SBS) disorder is related to poor absorption of nutrients. SBS is widely seen in patients who have undergone small parts' removal for their small-large intestines, significant damage of the small intestine, poor motility inside the intestines. People living with SBS cannot absorb sufficient water, minerals, fats, vitamins, protein, calories, and other nutrients from food. The symptoms of SBS can be mild, moderate, or severe. SBS is widely treated by medications, antibiotics, growth hormones, H2 blockers, and others.

MARKET DYNAMICS

The short bowel syndrome drugs market growth is estimated to grow due to the increasing incidences of short bowel syndrome, growing generic pharmaceutical productions, rising business expansions and more. The market is expected to have significant growth opportunities in the developing regions where the pharmaceutical industry is growing at rapid pace.

MARKET SCOPE

The "Short Bowel Syndrome Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Short bowel syndrome drugs market with detailed market segmentation by drug class, and distribution channel. The short bowel syndrome drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in short bowel syndrome drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The short bowel syndrome drugs market is segmented based on drug class, and distribution channel. Based on drug class, the market is classified as glucagon-like peptide, anti-diarrheals, proton pump inhibitors, histamine blockers, growth hormone, and others. And based on distribution channel, the market is segmented as hospital and retail pharmacies, and online distribution.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Short bowel syndrome drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The short bowel syndrome drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting short bowel syndrome drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the short bowel syndrome drugs market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the short bowel syndrome drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from short bowel syndrome drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for short bowel syndrome drugs market in the global market. Below mentioned is the list of few companies engaged in the short bowel syndrome drugs market.

The report also includes the profiles of key players in short bowel syndrome drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Takeda Pharmaceutical Company Limited
  •   Pfizer Inc.
  •   Novartis AG
  •   Mylan N.V.
  •   AstraZeneca Plc
  •   Sancilio Pharmaceuticals Company, Inc.
  •   Nutrinia Ltd
  •   Ardelyx, Inc.
  •   Merck and Co., Inc
  •   Zealand Pharma A/S

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Short Bowel Syndrome Drugs Market - By Drug Class
1.3.2 Short Bowel Syndrome Drugs Market - By Distribution Channel
1.3.3 Short Bowel Syndrome Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SHORT BOWEL SYNDROME DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SHORT BOWEL SYNDROME DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SHORT BOWEL SYNDROME DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. SHORT BOWEL SYNDROME DRUGS - GLOBAL MARKET OVERVIEW
6.2. SHORT BOWEL SYNDROME DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SHORT BOWEL SYNDROME DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. GLUCAGON-LIKE PEPTIDE
7.3.1. Overview
7.3.2. Glucagon-like Peptide Market Forecast and Analysis
7.4. ANTI-DIARRHEALS
7.4.1. Overview
7.4.2. Anti-Diarrheals Market Forecast and Analysis
7.5. PROTON PUMP INHIBITORS
7.5.1. Overview
7.5.2. Proton Pump Inhibitors Market Forecast and Analysis
7.6. HISTAMINE BLOCKERS
7.6.1. Overview
7.6.2. Histamine Blockers Market Forecast and Analysis
7.7. GROWTH HORMONE
7.7.1. Overview
7.7.2. Growth Hormone Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. SHORT BOWEL SYNDROME DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL AND RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
8.4. ONLINE DISTRIBUTION
8.4.1. Overview
8.4.2. Online Distribution Market Forecast and Analysis
9. SHORT BOWEL SYNDROME DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Short Bowel Syndrome Drugs Market Overview
9.1.2 North America Short Bowel Syndrome Drugs Market Forecasts and Analysis
9.1.3 North America Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Short Bowel Syndrome Drugs Market
9.1.5.1.1 United States Short Bowel Syndrome Drugs Market by Drug Class
9.1.5.1.2 United States Short Bowel Syndrome Drugs Market by Distribution Channel
9.1.5.2 Canada Short Bowel Syndrome Drugs Market
9.1.5.2.1 Canada Short Bowel Syndrome Drugs Market by Drug Class
9.1.5.2.2 Canada Short Bowel Syndrome Drugs Market by Distribution Channel
9.1.5.3 Mexico Short Bowel Syndrome Drugs Market
9.1.5.3.1 Mexico Short Bowel Syndrome Drugs Market by Drug Class
9.1.5.3.2 Mexico Short Bowel Syndrome Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Short Bowel Syndrome Drugs Market Overview
9.2.2 Europe Short Bowel Syndrome Drugs Market Forecasts and Analysis
9.2.3 Europe Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Short Bowel Syndrome Drugs Market
9.2.5.1.1 Germany Short Bowel Syndrome Drugs Market by Drug Class
9.2.5.1.2 Germany Short Bowel Syndrome Drugs Market by Distribution Channel
9.2.5.2 France Short Bowel Syndrome Drugs Market
9.2.5.2.1 France Short Bowel Syndrome Drugs Market by Drug Class
9.2.5.2.2 France Short Bowel Syndrome Drugs Market by Distribution Channel
9.2.5.3 Italy Short Bowel Syndrome Drugs Market
9.2.5.3.1 Italy Short Bowel Syndrome Drugs Market by Drug Class
9.2.5.3.2 Italy Short Bowel Syndrome Drugs Market by Distribution Channel
9.2.5.4 Spain Short Bowel Syndrome Drugs Market
9.2.5.4.1 Spain Short Bowel Syndrome Drugs Market by Drug Class
9.2.5.4.2 Spain Short Bowel Syndrome Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Short Bowel Syndrome Drugs Market
9.2.5.5.1 United Kingdom Short Bowel Syndrome Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Short Bowel Syndrome Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Short Bowel Syndrome Drugs Market
9.2.5.6.1 Rest of Europe Short Bowel Syndrome Drugs Market by Drug Class
9.2.5.6.2 Rest of Europe Short Bowel Syndrome Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Short Bowel Syndrome Drugs Market Overview
9.3.2 Asia-Pacific Short Bowel Syndrome Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Short Bowel Syndrome Drugs Market
9.3.5.1.1 Australia Short Bowel Syndrome Drugs Market by Drug Class
9.3.5.1.2 Australia Short Bowel Syndrome Drugs Market by Distribution Channel
9.3.5.2 China Short Bowel Syndrome Drugs Market
9.3.5.2.1 China Short Bowel Syndrome Drugs Market by Drug Class
9.3.5.2.2 China Short Bowel Syndrome Drugs Market by Distribution Channel
9.3.5.3 India Short Bowel Syndrome Drugs Market
9.3.5.3.1 India Short Bowel Syndrome Drugs Market by Drug Class
9.3.5.3.2 India Short Bowel Syndrome Drugs Market by Distribution Channel
9.3.5.4 Japan Short Bowel Syndrome Drugs Market
9.3.5.4.1 Japan Short Bowel Syndrome Drugs Market by Drug Class
9.3.5.4.2 Japan Short Bowel Syndrome Drugs Market by Distribution Channel
9.3.5.5 South Korea Short Bowel Syndrome Drugs Market
9.3.5.5.1 South Korea Short Bowel Syndrome Drugs Market by Drug Class
9.3.5.5.2 South Korea Short Bowel Syndrome Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Short Bowel Syndrome Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Short Bowel Syndrome Drugs Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Short Bowel Syndrome Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Short Bowel Syndrome Drugs Market Overview
9.4.2 Middle East and Africa Short Bowel Syndrome Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Short Bowel Syndrome Drugs Market
9.4.5.1.1 South Africa Short Bowel Syndrome Drugs Market by Drug Class
9.4.5.1.2 South Africa Short Bowel Syndrome Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Short Bowel Syndrome Drugs Market
9.4.5.2.1 Saudi Arabia Short Bowel Syndrome Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Short Bowel Syndrome Drugs Market by Distribution Channel
9.4.5.3 U.A.E Short Bowel Syndrome Drugs Market
9.4.5.3.1 U.A.E Short Bowel Syndrome Drugs Market by Drug Class
9.4.5.3.2 U.A.E Short Bowel Syndrome Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Short Bowel Syndrome Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Short Bowel Syndrome Drugs Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Short Bowel Syndrome Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Short Bowel Syndrome Drugs Market Overview
9.5.2 South and Central America Short Bowel Syndrome Drugs Market Forecasts and Analysis
9.5.3 South and Central America Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Short Bowel Syndrome Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Short Bowel Syndrome Drugs Market
9.5.5.1.1 Brazil Short Bowel Syndrome Drugs Market by Drug Class
9.5.5.1.2 Brazil Short Bowel Syndrome Drugs Market by Distribution Channel
9.5.5.2 Argentina Short Bowel Syndrome Drugs Market
9.5.5.2.1 Argentina Short Bowel Syndrome Drugs Market by Drug Class
9.5.5.2.2 Argentina Short Bowel Syndrome Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Short Bowel Syndrome Drugs Market
9.5.5.3.1 Rest of South and Central America Short Bowel Syndrome Drugs Market by Drug Class
9.5.5.3.2 Rest of South and Central America Short Bowel Syndrome Drugs Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SHORT BOWEL SYNDROME DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SHORT BOWEL SYNDROME DRUGS MARKET, KEY COMPANY PROFILES
12.1. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MYLAN N.V.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANCILIO PHARMACEUTICALS COMPANY, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NUTRINIA LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ARDELYX, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZEALAND PHARMA A/S
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Takeda Pharmaceutical Company Limited
2. Pfizer Inc.
3. Novartis AG
4. Mylan N.V.
5. AstraZeneca Plc
6. Sancilio Pharmaceuticals Company, Inc.
7. Nutrinia Ltd
8. Ardelyx, Inc.
9. Merck and Co., Inc
10. Zealand Pharma A/S
11. Emmaus Life Sciences, Inc.
12. OxThera
13. Naia Pharmaceuticals, Inc.
14. Nestlé S.A.
15. VectivBio AG
TIPRE00021601
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved